ipatherapeutics.com (HYFT): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand MindWalk Holdings (HYFT)

MindWalk Holdings (HYFT) is developing medical AI services through partnerships with clinics, although a revenue deficit is leading to the depletion of reserves. The P/E to growth ratio on this GURU.Markets platform chart confirms the trend, where the current figure stands at 0.00. Meanwhile, the scalable bioplatform for drug discovery drives revenue growth through capital-expenditure-free licensing.

HYFT - MindWalk Holdings, Inc. PEG Multiple over the range 09/05/2025 - 11/16/2026

Metric breakdowns and analytics for MindWalk Holdings Inc. (HYFT)

- share price and consensus valuation forecast:
Fundamental company analysis:HYFT (MindWalk)
Mass-produced product of ipatherapeutics.com

The PEG ratio compares the market value of earnings to their growth rate. Investors utilize this formula to identify undervalued assets where growth outpaces the P/E multiple. Analyzing the balance between the P/E ratio and growth allows for the real-time assessment of market imbalances without time lags. Values below one signal high potential for MindWalk Holdings (HYFT). The diversification of AI platforms in healthcare provides the company with sustainable profit dynamics.

Competing companies

HLN - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Kenvue Inc KVUE|Verona Pharma (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|Ligand - Company Value to Earnings Growth Ratio|AMRX: PEG Multiple|Perrigo Company - Growth-Adjusted Payback Ratio|ALVO (Alvotech S.A.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate liquidia.com LQDA|Price/Earnings to Growth Ratio Galapagos (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Afrezza MNKD|PEG Multiple Amphastar Corp AMPH|Pacira Corp - PEG Multiple|Growth-Adjusted Payback Ratio SPRY (ars-pharma.com)|TBPH: PEG Multiple|Aquestive Therapeutics, Inc. (AQST) - PEG Multiple|SCPH (scpharmaceuticals.com) - PEG Multiple|TECX (tectonictx.com) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple TNXP (Tonix Pharmaceuticals Holding Corp.)|PEG Multiple SXT China (SXTC)|eupraxiapharma.com - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BHST|invizyne.com - PEG Multiple|Growth-Adjusted Payback Ratio ORMP (Oramed Pharmaceuticals Inc.)|ENTX: PEG Multiple|Price to Earnings Adjusted for Growth Rate abvcpharma.com (ABVC)|Price/Earnings to Growth Ratio Cumberland Pharma|Price/Earnings to Growth Ratio QNTM|PEG Multiple FGEN|TELO (Telomir Pharma) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Rani Therapeutics Holdings RANI|SNYR - Price/Earnings to Growth Multiple|RLYB - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income lexariabioscience.com LEXX|PULM: PEG Multiple|Growth-Adjusted P/E Ratio PTHL|Price/Earnings to Growth Ratio Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Company Value to Earnings Growth Ratio|PEG Multiple IBO|Growth-Adjusted Market Cap to Net Income TNF Pharmaceuticals, Inc.|PEG Multiple YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Market Cap to Earnings and Growth Ratio|CYTO: Price/Earnings to Growth Multiple|LIPO - PEG Multiple|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|PIRS - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Procaps|Price/Earnings to Growth Multiple Petros (PTPI)|Price/Earnings to Growth Ratio Qilian International Corp (QLI)|PEG Multiple acelyrin.com (SLRN)|PEG Multiple TFFP (TFF Pharmaceuticals)